NMIH Q1 2026 Earnings EPS Beats Estimates Shares Edge Lower CLNN Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Ongoing Clinical Progress KUST Q4 2025 Earnings Deep EPS Miss Sparks Cautious Reaction ONB Q1 2026 Earnings Slight EPS Miss Amid Stable Market Conditions TSM Q1 2026 Earnings Strong EPS Beat Signals Robust Demand Amid Cautious Market Response LCTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline